HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.

Abstract
Sirtuin genes have been associated with aging and are known to affect multiple cellular pathways. Sirtuin 2 was previously shown to modulate proteotoxicity associated with age-associated neurodegenerative disorders such as Alzheimer and Parkinson disease (PD). However, the precise molecular mechanisms involved remain unclear. Here, we provide mechanistic insight into the interplay between sirtuin 2 and α-synuclein, the major component of the pathognomonic protein inclusions in PD and other synucleinopathies. We found that α-synuclein is acetylated on lysines 6 and 10 and that these residues are deacetylated by sirtuin 2. Genetic manipulation of sirtuin 2 levels in vitro and in vivo modulates the levels of α-synuclein acetylation, its aggregation, and autophagy. Strikingly, mutants blocking acetylation exacerbate α-synuclein toxicity in vivo, in the substantia nigra of rats. Our study identifies α-synuclein acetylation as a key regulatory mechanism governing α-synuclein aggregation and toxicity, demonstrating the potential therapeutic value of sirtuin 2 inhibition in synucleinopathies.
AuthorsRita Machado de Oliveira, Hugo Vicente Miranda, Laetitia Francelle, Raquel Pinho, Éva M Szegö, Renato Martinho, Francesca Munari, Diana F Lázaro, Sébastien Moniot, Patrícia Guerreiro, Luis Fonseca-Ornelas, Zrinka Marijanovic, Pedro Antas, Ellen Gerhardt, Francisco Javier Enguita, Bruno Fauvet, Deborah Penque, Teresa Faria Pais, Qiang Tong, Stefan Becker, Sebastian Kügler, Hilal Ahmed Lashuel, Clemens Steegborn, Markus Zweckstetter, Tiago Fleming Outeiro
JournalPLoS biology (PLoS Biol) Vol. 15 Issue 3 Pg. e2000374 (03 2017) ISSN: 1545-7885 [Electronic] United States
PMID28257421 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Aggregates
  • alpha-Synuclein
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Sirtuin 2
  • Lysine
Topics
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Acetylation (drug effects)
  • Animals
  • Autophagy (drug effects)
  • Cell Membrane (drug effects, metabolism)
  • Cells, Cultured
  • Cerebral Cortex (pathology)
  • Disease Models, Animal
  • Dopaminergic Neurons (drug effects, metabolism)
  • Gene Deletion
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Lysine (metabolism)
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mutation (genetics)
  • Neuroprotection (drug effects)
  • Parkinson Disease (metabolism, pathology)
  • Protein Aggregates (drug effects)
  • Protein Binding
  • Sirtuin 2 (metabolism)
  • alpha-Synuclein (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: